Pharmaceuticals and Biotech | Media Room

Press Release Oct 18, 2018

Upcoming Xtalks Webinar: Clinical Supply Planning Optimization

Press Release Oct 17, 2018

Sponsor-Facilitated Relationships Between Late Stage Researchers and Phase 1 Sites: A Novel Model for Early Phase Studies, New Webinar Hosted by Xtalks

Press Release Oct 17, 2018

Solving Medical Technology Product Development Issues, New Webinar Hosted by Xtalks

Press Release Oct 16, 2018

Pfizer and Bracket - How to Apply Patient-Centric Concepts to All Stages of Clinical Trials, New Webinar Hosted by Xtalks

Much of the discussion around patient-centricity today is centered around trial design, which is important and commendable work. Unfortunately, focusing primarily on design overlooks how to instill patient-centric concepts and create a friendly environment in the study once the protocol is finalized. Read More

Press Release Oct 16, 2018

Fit-for-Future Pharmacovigilance Sourcing Strategies, New Webinar Hosted by Xtalks

Press Release Oct 15, 2018

NeuroDiagnostics, LLC New Alzheimer's Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration

DISCERN™ is the most accurate, least invasive and most cost-effective test for identifying Alzheimer's Disease Read More

Press Release Oct 15, 2018

Alpha Genesis Indonesian Macaques Show Unique Research Potential

Genetic analysis reveals previously unknown qualities that could hold the key for developing innovative medical therapies and cures Read More

Press Release Oct 15, 2018

How to Destroy Clinical Data Silos, New Webinar Hosted by Xtalks

Press Release Oct 15, 2018

How Animal Behavioral Management and Environmental Enrichment Enhances Preclinical Research Performance, New Webinar Hosted by Xtalks

Press Release Oct 15, 2018

Diagnomics Partners With Translational Software to Launch Pharmacogenetic Testing Services in the United States

Partnership offers PGx solutions on advanced genotyping array to enable precision medicine Read More

Press Release Oct 15, 2018

TRI Raises Multi-Million Growth Funding From Octopus Investments to Expand Its Risk-Based Monitoring Platform for Clinical Trials

Press Release Oct 12, 2018

Trends in Site Payments: Insight Into How CROs Can Gain a Competitive Edge, New Webinar Hosted by Xtalks

Press Release Oct 12, 2018

Applying the Latest Digital Technology Trends to Patient, Provider and Payer Communications, New Webinar Hosted by Xtalks

Press Release Oct 12, 2018

Ken Abramowitz, Co-Founder & Managing Partner of NGN Capital, Joins InvestAcure, PBC as Chief Investment Officer

Press Release Oct 11, 2018

First Light Biosciences Announces Funding From Biomedical Advanced Research and Development Authority (BARDA)

A contract extension representing $10.7 million over two years Read More

Press Release Oct 11, 2018

Getting the Most Out of Interactive Response Technology in Clinical Trial Supply, New Webinar Hosted by Xtalks

Press Release Oct 11, 2018

Transforming Clinical Trial Operations: The Next Big Step, New Webinar Hosted by Xtalk

Press Release Oct 11, 2018

Demystifying IRT Terminology, New Webinar Hosted by Xtalks

Press Release Oct 10, 2018

Vascular Stress Contributes to Age-Associated Vision Loss

Press Release Oct 10, 2018

TherigySTM™ Surpasses 100 Million Specialty Patient Responses

The trusted specialty pharmacy software and consulting company has reached a significant milestone in therapy management support Read More

Press Release Oct 9, 2018

Dr. Ralph Landau Appointed to the Role of President of Frontida BioPharm, Inc.

Press Release Oct 8, 2018

ClinOne Offers Study Sponsors and CROs Immediate and Continuous Patient Study Feedback, Measurement During Clinical Trial Participation

Press Release Oct 8, 2018

Inhalation Drug Delivery: Considerations for Toxicology and Pharmacology Research, New Webinar Hosted by Xtalks

Press Release Oct 5, 2018

FDA Grants Coordination Pharmaceuticals IND Approval for CPI-100, a Novel Antitumor Nanomedicine

Press Release Oct 4, 2018

Therigy Outcomes Contributions Recognized by National Association of Specialty Pharmacy

Therigy's winning scientific poster at the NASP Annual Meeting demonstrates the power of technology-enabled support of specialty patients. Read More

Press Release Oct 4, 2018

Fluorescently-Labeled Peptides - Choosing the Best Dye and Designing the Best Peptide, New Webinar Hosted by Xtalks

Press Release Oct 4, 2018

Better Target Validation for Drug Discovery With CRISPR/Cas9, New Webinar Hosted by Xtalks

Better target validation is a key driver of better productivity in drug discovery. The RNA-guided nucleases, exemplified by Cas9, represent a powerful new approach to understanding gene function and, in principle, to reveal the next generation of therapeutic targets. But how well does this technology work in practice? Read More

Press Release Oct 3, 2018

EastGate Biotech Receives Approval to Commence a Phase 2 Trial for Liquid Insulin Mouth Rinse Solution Addressing Patient Compliance in the Type 2 Diabetes Market

DRAP (Drug Regulatory Authority Pakistan) provided approval to commence studies of INSUGIN in Pakistan Read More

Press Release Oct 3, 2018

International Association of Women Recognizes Nancy Alexander as a 2018-2019 Influencer

Nancy Alexander, Account Director, Southeast at Sanofi Genzyme, joins networking organization Read More

Press Release Oct 3, 2018

Digital Health: Optimizing Clinical Trials With Patient-Centric Technology, New Webinar Hosted by Xtalks

Press Release Oct 3, 2018

Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials, New Webinar Hosted by Xtalks

Press Release Oct 2, 2018

Interventional vs. Non-Interventional: Considerations for Correctly Classifying Your Clinical Study, New Webinar Hosted by Xtalks

Press Release Oct 2, 2018

Make Better Pharmaceutical Portfolio Decisions - Using Failure Rates to Understand Portfolio Risks and Improve R&D Productivity, New Webinar Hosted by Xtalks

Numerous studies have analyzed R&D productivity and measured drug approval rates, but an analysis focused on success rates has limitations, providing only one piece to the puzzle. Read More

Press Release Oct 2, 2018

Renal Trials in the Asia Pacific: Where Are We & What Does the Future Hold? a George Clinical Webinar Hosted by Xtalks

Press Release Oct 2, 2018

Purchase Power is Back in the Hands of Independent Pharmacies

Members Standing Together in Fighting Price Hikes Read More

Press Release Oct 1, 2018

Strategic Implementation of a Rapid Molecular Blood Culture Panel for Gram-Negative Bacteremia, New Webinar Hosted by Xtalks

Press Release Oct 1, 2018

Upcoming Xtalks Webinar: A Better Predictive Model for Oncology Drug Development Beyond Traditional Platforms

Delineation of the intra-tumor microenvironment in a dynamic, spatiotemporal setting is critical for investigating the activity and efficacy of candidate oncology drugs. The majority of solid cancers contain unorganized, highly complex microenvironments wherein a dysregulated phenotype impacts treatment outcomes at a personalized level. Read More

Press Release Sep 28, 2018

Venerated and Vital: Using Lipid Based Delivery for Fast and Efficient Early Phase Development, Upcoming Webinar Hosted by Xtalks

Press Release Sep 27, 2018

Captek | Pharma Exhibiting at Contract Pharma Conference in 2018, Booth 151

Press Release Sep 27, 2018

TARA Biosystems Announces Launch of Cardiotype.Fo, Best-in-Class In Vitro Assay for Assessment of Cardiac Contractility

Press Release Sep 27, 2018

Routes to Improve Pediatric Patient Engagement in Clinical Trials -- New Webinar Hosted by Xtalks

Press Release Sep 27, 2018

Quality In, Quality Out: Best Practices and Tools for Supplier Quality Management (Part 4 of 4), New Webinar Hosted by Xtalks

In this presentation, the last in a 4-part webinar series examining supplier quality management for the pharmaceutical and medical device industries, the featured speaker will explore the technology options for managing a supplier quality management program within a centralized cloud-based network that supports all supplier-related procedures and processes. Read More

Press Release Sep 27, 2018

Analysis of Over 1,000 Atopic Dermatitis Patients Highlights Moderate-to-Severe Patient Candidacy for Biologics and Small Molecules and Real-World Treatment Patterns for Patients Treated With Sanofi/Regeneron's Dupixent

Candidacy analysis for pipeline agents reveals that JAK inhibitors, such as Pfizer's PF-0496582, AbbVie's upadacitinib and Incyte's topical ruxolitinib have the most potential upside if approved Read More

Press Release Sep 27, 2018

Sir William Castell Joins the Board of Phoenix Solutions AS, a Private Norwegian Biotechnology Company Harnessing the Power of Ultrasound for Targeted Drug Delivery

Press Release Sep 26, 2018

Using Interactive Response Technology to Implement Bayesian Futility Analysis in Basket Trials

Live webinar on Thursday, October 11, 2018 to examine the adoption of basket and umbrella trials in oncology drug development Read More

Press Release Sep 26, 2018

Aronora's New Blood Clot Treatment Receives FDA Fast Track Designation

Enzyme that selectively targets blood clots has received FDA Fast Track designation, allowing for expedited clinical development Read More

Press Release Sep 24, 2018

Identifying Spatial Expression Patterns in the Tumor Microenvironment, New Webinar Hosted by Xtalks

Press Release Sep 21, 2018

Dr. Bob Raffa Joins Bridge Therapeutics' Scientific Advisory Board Bringing Decades of Research and Experience

Pharmaceutical startup Bridge Therapeutics announces the addition of Dr. Bob Raffa as its newest Scientific Advisory Board member. Read More

Press Release Sep 20, 2018

Synthetic Biology Making Strides in Key Applications Finds IDTechEx

Press Release Sep 19, 2018

Genentech's Ocrevus Positioning as an Appropriate First-Line Option in Relapsing Remitting Multiple Sclerosis Appears to Be Resonating With a Subset of U.S. Neurologists

Unaided awareness of EMD Serono's Mavenclad (cladribine tablets) and Novartis' siponimod increased compared to previous quarters, but neurologists appear split on how, or if, they will incorporate the newest agents into their multiple sclerosis armamentarium, according to a new report from Spherix Global Insights Read More

Press Release Sep 18, 2018

Crack the Code: 3 Defining Steps to Unlock Medical Technology Commercialization Potential

Press Release Sep 18, 2018

Apprentice.io Raises $8M Series A for First Conversational AR and AI Platform

Pritzker Group Venture Capital Leads Round, Pushing Apprentice past $10M Mark Read More

Press Release Sep 17, 2018

Decoding eClinical Software: CTMS Evaluation for the Non-IT Professional, New Webinar Hosted by Xtalks

Press Release Sep 17, 2018

American Associated Pharmacies Agrees to Acquire Remaining 50 Percent Stake in Arete Pharmacy Network, LLC

Arete Pharmacy Network to become wholly owned Read More

Press Release Sep 17, 2018

Is Your Biotherapeutic Immunogenic? How to Use Immunoassays to Get the Right Answer -- New Webinar Hosted by Xtalks

Press Release Sep 17, 2018

Configuration in ePRO: Making Design More Collaborative and Delivering Better Results, New Webinar Hosted by Xtalks

Press Release Sep 17, 2018

Data Validity and Regulatory-Grade Real World Evidence, New Webinar Hosted by Xtalks

Data validity is the cornerstone of evidence-based medicine. As randomized controlled trials are augmented by real-world evidence, data validity has come under question. Read More

Press Release Sep 14, 2018

The Importance of Fueling Your Clinical Supply Chain, New Webinar Hosted by Xtalks

Press Release Sep 14, 2018

Genome-Scale CRISPR Screens: Strategies to Prioritise and Validate Potential Targets, New Webinar Hosted by Xtalks

Initial excitement associated with the completion of genome-scale CRISPR screens can quickly turn to dismay as the realization of the sheer quantity of data generated becomes apparent. Read More

Press Release Sep 14, 2018

Latest Biologic Launch in Psoriasis, UCB's Cimzia, Having a Tough Time Getting Traction, But Developing a Presence in Dermatology May Lay Foundation for Bimekizumab in the Future

Janssen's Tremfya continues to post gains, but may soon face competition as Sun Dermatology readies for the launch of Ilumya (tildrakizumab), the second IL-23 inhibitor to be introduced in the U.S. market, according to a new report from Spherix Global Insights Read More